DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel

Abstract

The region consisting of the first and second variable regions (V1V2) of gp120 plays vital roles in the functioning of the HIV-1 envelope (Env). V1V2, which harbors multiple glycans and is highly sequence diverse, is located at the Env apex and stabilizes the trimeric gp120 spike on the virion surface. It shields V3 and the coreceptor binding sites in the prefusion state and exposes them upon CD4 binding. Data from the RV144 human HIV-1 vaccine trial suggested that antibody responses targeting the V1V2 region inversely correlated with the risk of infection; thus, understanding the antigenic structure of V1V2 can contribute to vaccine design. We have determined a crystal structure of a V1V2 scaffold molecule (V1V2ZM109-1FD6) in complex with 830A, a human monoclonal antibody that recognizes a V1V2 epitope overlapping the integrin-binding motif in V2. The structure revealed that V1V2 assumes a five-stranded beta barrel structure with the region of the integrin-binding site (amino acids [aa] 179 to 181) included in a “kink” followed by an extra beta strand. The complete barrel structure naturally presents the glycans on its outer surface and packs into its core conserved hydrophobic residues, including the Ile at position 181 which was highly correlated with vaccinemore » efficacy in RV144. The epitope of monoclonal antibody 830A is discontinuous and composed of three segments: (i) Thr175, Tyr177, Leu179, and Asp180at the kink overlapping the integrin-binding site; (ii) Arg153and Val154in V1; and (iii) Ile194at the C terminus of V2. Here, this report thus provides the atomic details of the immunogenic “V2i epitope.”« less

Authors:
 [1];  [1];  [2];  [1]
  1. NYU School of Medicine, NY (United States)
  2. NYU School of Medicine, NY (United States); Veterans Affairs New York Harbor Healthcare System, New York, NY (United States)
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Basic Energy Sciences (BES); National Inst. of Health; National Cancer Inst.; National Inst. of General Medical Sciences
OSTI Identifier:
1213733
Grant/Contract Number:  
AC02-06CH11357; AI100151; AI082274; AI084119; HL059725; Y1-CO-1020; Y1-GM-1104
Resource Type:
Accepted Manuscript
Journal Name:
Journal of Virology
Additional Journal Information:
Journal Volume: 89; Journal Issue: 15; Journal ID: ISSN 0022-538X
Publisher:
American Society for Microbiology
Country of Publication:
United States
Language:
ENGLISH
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Pan, Ruimin, Gorny, Miroslaw K., Zolla-Pazner, Susan, and Kong, Xiang-Peng. The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel. United States: N. p., 2015. Web. doi:10.1128/JVI.00754-15.
Pan, Ruimin, Gorny, Miroslaw K., Zolla-Pazner, Susan, & Kong, Xiang-Peng. The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel. United States. https://doi.org/10.1128/JVI.00754-15
Pan, Ruimin, Gorny, Miroslaw K., Zolla-Pazner, Susan, and Kong, Xiang-Peng. Wed . "The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel". United States. https://doi.org/10.1128/JVI.00754-15. https://www.osti.gov/servlets/purl/1213733.
@article{osti_1213733,
title = {The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel},
author = {Pan, Ruimin and Gorny, Miroslaw K. and Zolla-Pazner, Susan and Kong, Xiang-Peng},
abstractNote = {The region consisting of the first and second variable regions (V1V2) of gp120 plays vital roles in the functioning of the HIV-1 envelope (Env). V1V2, which harbors multiple glycans and is highly sequence diverse, is located at the Env apex and stabilizes the trimeric gp120 spike on the virion surface. It shields V3 and the coreceptor binding sites in the prefusion state and exposes them upon CD4 binding. Data from the RV144 human HIV-1 vaccine trial suggested that antibody responses targeting the V1V2 region inversely correlated with the risk of infection; thus, understanding the antigenic structure of V1V2 can contribute to vaccine design. We have determined a crystal structure of a V1V2 scaffold molecule (V1V2ZM109-1FD6) in complex with 830A, a human monoclonal antibody that recognizes a V1V2 epitope overlapping the integrin-binding motif in V2. The structure revealed that V1V2 assumes a five-stranded beta barrel structure with the region of the integrin-binding site (amino acids [aa] 179 to 181) included in a “kink” followed by an extra beta strand. The complete barrel structure naturally presents the glycans on its outer surface and packs into its core conserved hydrophobic residues, including the Ile at position 181 which was highly correlated with vaccine efficacy in RV144. The epitope of monoclonal antibody 830A is discontinuous and composed of three segments: (i) Thr175, Tyr177, Leu179, and Asp180at the kink overlapping the integrin-binding site; (ii) Arg153and Val154in V1; and (iii) Ile194at the C terminus of V2. Here, this report thus provides the atomic details of the immunogenic “V2i epitope.”},
doi = {10.1128/JVI.00754-15},
journal = {Journal of Virology},
number = 15,
volume = 89,
place = {United States},
year = {Wed Jul 08 00:00:00 EDT 2015},
month = {Wed Jul 08 00:00:00 EDT 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 49 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Structure and immune recognition of trimeric pre-fusion HIV-1 Env
journal, October 2014

  • Pancera, Marie; Zhou, Tongqing; Druz, Aliaksandr
  • Nature, Vol. 514, Issue 7523
  • DOI: 10.1038/nature13808

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
journal, June 1998


Epitope Mapping of Conformational V2-specific Anti-HIV Human Monoclonal Antibodies Reveals an Immunodominant Site in V2
journal, July 2013


Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
journal, November 2011

  • McLellan, Jason S.; Pancera, Marie; Carrico, Chris
  • Nature, Vol. 480, Issue 7377
  • DOI: 10.1038/nature10696

Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
journal, February 2014


Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16
journal, May 2013

  • Pancera, Marie; Shahzad-ul-Hussan, Syed; Doria-Rose, Nicole A.
  • Nature Structural & Molecular Biology, Vol. 20, Issue 7
  • DOI: 10.1038/nsmb.2600

Structural specializations of α 4 β 7 , an integrin that mediates rolling adhesion
journal, January 2012

  • Yu, Yamei; Zhu, Jianghai; Mi, Li-Zhi
  • The Journal of Cell Biology, Vol. 196, Issue 1
  • DOI: 10.1083/jcb.201110023

Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection
journal, November 2014

  • Byrareddy, Siddappa N.; Kallam, Brianne; Arthos, James
  • Nature Medicine, Vol. 20, Issue 12
  • DOI: 10.1038/nm.3715

Distinct Mechanisms Regulate Exposure of Neutralizing Epitopes in the V2 and V3 Loops of HIV-1 Envelope
journal, August 2014

  • Upadhyay, C.; Mayr, L. M.; Zhang, J.
  • Journal of Virology, Vol. 88, Issue 21
  • DOI: 10.1128/JVI.02125-14

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
journal, April 2012

  • Haynes, Barton F.; Gilbert, Peter B.; McElrath, M. Juliana
  • New England Journal of Medicine, Vol. 366, Issue 14
  • DOI: 10.1056/NEJMoa1113425

Structure of a V3-Containing HIV-1 gp120 Core
journal, November 2005


Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
journal, June 1998

  • Kwong, Peter D.; Wyatt, Richard; Robinson, James
  • Nature, Vol. 393, Issue 6686
  • DOI: 10.1038/31405

Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
journal, September 2012

  • Rolland, Morgane; Edlefsen, Paul T.; Larsen, Brendan B.
  • Nature, Vol. 490, Issue 7420
  • DOI: 10.1038/nature11519

PHENIX : building new software for automated crystallographic structure determination
journal, October 2002

  • Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li-Wei
  • Acta Crystallographica Section D Biological Crystallography, Vol. 58, Issue 11
  • DOI: 10.1107/S0907444902016657

Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
journal, October 2013


Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals
journal, June 2012


Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer
journal, October 2013


XDS
journal, January 2010

  • Kabsch, Wolfgang
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2
  • DOI: 10.1107/S0907444909047337

Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold
journal, September 2010


Cross-Clade HIV-1 Neutralizing Antibodies Induced with V3-Scaffold Protein Immunogens following Priming with gp120 DNA
journal, July 2011

  • Zolla-Pazner, S.; Kong, X. - P.; Jiang, X.
  • Journal of Virology, Vol. 85, Issue 19
  • DOI: 10.1128/JVI.05086-11

Structure–function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design
journal, July 2010

  • Zolla-Pazner, Susan; Cardozo, Timothy
  • Nature Reviews Immunology, Vol. 10, Issue 7
  • DOI: 10.1038/nri2801

HIV-1 Envelope Subregion Length Variation during Disease Progression
journal, December 2010


Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
journal, September 2009


Quaternary Epitope Specificities of Anti-HIV-1 Neutralizing Antibodies Generated in Rhesus Macaques Infected by the Simian/Human Immunodeficiency Virus SHIVSF162P4
journal, January 2010

  • Robinson, James E.; Franco, Kelly; Elliott, Debra Holton
  • Journal of Virology, Vol. 84, Issue 7
  • DOI: 10.1128/JVI.02617-09

Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
journal, January 2013


HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells
journal, February 2008

  • Arthos, James; Cicala, Claudia; Martinelli, Elena
  • Nature Immunology, Vol. 9, Issue 3
  • DOI: 10.1038/ni1566

ICM?A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation
journal, May 1994

  • Abagyan, Ruben; Totrov, Maxim; Kuznetsov, Dmitry
  • Journal of Computational Chemistry, Vol. 15, Issue 5
  • DOI: 10.1002/jcc.540150503

Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.
journal, January 1994


A Twin-Cysteine Motif in the V2 Region of gp120 Is Associated with SIV Envelope Trimer Stabilization
journal, July 2013


Identification of a New Quaternary Neutralizing Epitope on Human Immunodeficiency Virus Type 1 Virus Particles
journal, April 2005


Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope
journal, August 2014


Protein modules and signalling networks
journal, February 1995


Complete Nucleotide Sequences of Functional Clones of the AIDS Virus
journal, January 1987

  • Ratner, Lee; Fisher, Amanda; Jagodzinski, Linda L.
  • AIDS Research and Human Retroviruses, Vol. 3, Issue 1
  • DOI: 10.1089/aid.1987.3.57

Functional Implications of the Binding Mode of a Human Conformation-Dependent V2 Monoclonal Antibody against HIV
journal, January 2014

  • Spurrier, B.; Sampson, J.; Gorny, M. K.
  • Journal of Virology, Vol. 88, Issue 8
  • DOI: 10.1128/JVI.03153-13

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
journal, December 2002

  • Kwong, Peter D.; Doyle, Michael L.; Casper, David J.
  • Nature, Vol. 420, Issue 6916
  • DOI: 10.1038/nature01188

[20] Processing of X-ray diffraction data collected in oscillation mode
book, January 1997


Works referencing / citing this record:

Alterations of HIV-1 envelope phenotype and antibody-mediated neutralization by signal peptide mutations
journal, January 2018


The β20–β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions
journal, October 2017


Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers
journal, April 2018

  • Castillo-Menendez, Luis R.; Witt, Kristen; Espy, Nicole
  • Journal of Virology, Vol. 92, Issue 12
  • DOI: 10.1128/jvi.00277-18

Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity
journal, October 2017


Opening dynamics of HIV-1 gp120 upon receptor binding is dictated by a key hydrophobic core
journal, January 2019

  • Da, Lin-Tai; Lin, Mengna
  • Physical Chemistry Chemical Physics, Vol. 21, Issue 47
  • DOI: 10.1039/c9cp04613e

Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7
journal, August 2018


Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions
journal, October 2018

  • Wibmer, Constantinos Kurt; Richardson, Simone I.; Yolitz, Jason
  • Nature Communications, Vol. 9, Issue 1
  • DOI: 10.1038/s41467-018-06794-x

Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials
journal, January 2018

  • Balasubramanian, Preetha; Williams, Constance; Shapiro, Mariya B.
  • Scientific Reports, Vol. 8, Issue 1
  • DOI: 10.1038/s41598-017-18863-0

Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response
journal, September 2016

  • Zolla-Pazner, Susan; Powell, Rebecca; Yahyaei, Sara
  • Journal of Virology, Vol. 90, Issue 24
  • DOI: 10.1128/jvi.01403-16

Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
journal, December 2015

  • Gorman, Jason; Soto, Cinque; Yang, Max M.
  • Nature Structural & Molecular Biology, Vol. 23, Issue 1
  • DOI: 10.1038/nsmb.3144